117 related articles for article (PubMed ID: 9728806)
1. Characterization of anti-erythrocyte autoantibodies in non-Hodgkin's lymphoma patients in Brazil.
Barjas de Castro ML; Locatelli MF; de Castilho LM; de Souza CA
Haematologia (Budap); 1998; 29(2):139-45. PubMed ID: 9728806
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma.
Bairey O; Blickstein D; Monselise Y; Lahav J; Stark P; Prokocimer M; Nativ HM; Kirgner I; Pazgal I; Shaklai M
Eur J Haematol; 2006 May; 76(5):384-91. PubMed ID: 16466368
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of anticentromere F protein autoantibodies in 347 patients with non-Hodgkin's lymphoma.
Bencimon C; Salles G; Moreira A; Guyomard S; Coiffier B; Bienvenu J; Fabien N
Ann N Y Acad Sci; 2005 Jun; 1050():319-26. PubMed ID: 16014548
[TBL] [Abstract][Full Text] [Related]
4. The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?
Bilici A; Yapici HS; Ercan S; Seker M; Ustaalioglu BB; Salman T; Orcun A; Gumus M
J BUON; 2012; 17(3):502-7. PubMed ID: 23033289
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal immunoglobulins and autoantibodies in lymphoid malignancies.
Katsikis PD; Pavlidis NA; Papadopoulos NM; Bai M; Moutsopoulos HM
Anticancer Res; 1990; 10(6):1719-24. PubMed ID: 2285248
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
7. The circulating auto-antibodies to p53 protein in the follow-up of lymphoma patients.
Jezersek B; Rudolf Z; Novakovic S
Oncol Rep; 2001; 8(1):77-81. PubMed ID: 11115573
[TBL] [Abstract][Full Text] [Related]
8. [Autoimmune haemolytic anaemia associated with Hodgkin's disease. Characteristics, prognosis and incidence (author's transl)].
Andrieu JM; Youinou P; Marcelli A
Nouv Presse Med; 1981 Oct; 10(36):2951-4. PubMed ID: 7290949
[TBL] [Abstract][Full Text] [Related]
9. Identification of L-plastin autoantibody in plasma of patients with non-Hodgkin's lymphoma using a proteomics-based analysis.
Ueda K; Nakanishi T; Shimizu A; Takubo T; Matsuura N
Ann Clin Biochem; 2008 Jan; 45(Pt 1):65-9. PubMed ID: 18275676
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune haemolysis and red cell autoantibodies with ABO blood group specificity.
Sokol RJ; Booker DJ; Stamps R; Windle JA
Haematologia (Budap); 1995; 26(3):121-9. PubMed ID: 7797142
[TBL] [Abstract][Full Text] [Related]
12. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
[TBL] [Abstract][Full Text] [Related]
13. [Primary gastric non-Hodgkin's lymphoma: clinical findings and prognostic factors].
Guzicka-Kazimierczak R
Ann Acad Med Stetin; 2006; 52(3):77-84; discussion 84. PubMed ID: 17385352
[TBL] [Abstract][Full Text] [Related]
14. [Multiple autoantibodies in the course of Hodgkin's disease: interpretation of erythroblastopenia].
Guerra L; Najman A; Homberg JC; Duhamel G; André R
Nouv Rev Fr Hematol; 1969; 9(5):601-10. PubMed ID: 4244262
[No Abstract] [Full Text] [Related]
15. Localized B-cell non-Hodgkin's lymphoma of oral cavity and maxillofacial region: a clinical study.
Kolokotronis A; Konstantinou N; Christakis I; Papadimitriou P; Matiakis A; Zaraboukas T; Antoniades D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):303-10. PubMed ID: 15716836
[TBL] [Abstract][Full Text] [Related]
16. A direct enzyme-linked antiglobulin test for detection of red cell autoantibodies in auto-immune haemolytic anaemia.
Leach M
Med Lab Sci; 1984 Jul; 41(3):232-7. PubMed ID: 6482692
[No Abstract] [Full Text] [Related]
17. Prevalence of hepatitis C infection in patients with non-Hodgkin's lymphomas.
Chindamo MC; Spector N; Segadas JA; Pimenta G; Vanderborght B; Morais JC; Milito C; Moraes Coelho HS
Oncol Rep; 2002; 9(3):657-9. PubMed ID: 11956646
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study of erythrocyte antibodies].
Tsunematsu T
Rinsho Byori; 1969 Mar; 17(3):210-4. PubMed ID: 4185046
[No Abstract] [Full Text] [Related]
19. [Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma].
Pérez Encinas M; Bello JL; Bendaña A; Rabuñal MJ; González S; Abuín I; Noya M; Cadarso C
Med Clin (Barc); 1998 Jul; 111(5):161-7. PubMed ID: 9732831
[TBL] [Abstract][Full Text] [Related]
20. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma.
Daum S; Ullrich R; Heise W; Dederke B; Foss HD; Stein H; Thiel E; Zeitz M; Riecken EO
J Clin Oncol; 2003 Jul; 21(14):2740-6. PubMed ID: 12860953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
